AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- 1 awardAwards on record
Market overview
Fundamentals Oct 5- Open
- $37.02
- 52-wk high
- $39.76
- High
- $37.98
- 52-wk low
- $17.86
- Low
- $36.83
- Prev close
- $36.78
- Mkt cap
- $1.82B
- P/E
- 37.3x
- Volume
- 2.85M
- Fwd P/E
- 238.1x
- Beta
- 1.92
- P/S
- 17.1x
- P/B
- 4.4x
- Profit margin
- +54.3%
- Op margin
- +6.0%
- ROE
- +12.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about BLFS filings
Are insiders buying or selling BioLife Solutions Inc (BLFS) stock?
Neither. BioLife Solutions Inc (BLFS) insiders filed no open-market purchases or sales in the 90 days to Oct 5, 2026, according to SEC Form 4 filings.
Which members of Congress have traded BLFS recently?
None. No member of Congress disclosed a BLFS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this BLFS smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BO
Bank of America
$4.6M
added
What insiders are doing
Sells (1)
- CP
Casdin Partners Master Fund, L.P.
$28.1M
sold
How top traders are positioned
No tracked top-trader positions in BLFS right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in $0.05 a share above what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.01 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.04 / -$0.01Alpha Vantage | +$0.05 beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.04 / $0.02Alpha Vantage | +$0.02 beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | $0.04 / -$0.02Alpha Vantage | +$0.06 beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.04 / -$0.01Alpha Vantage | +$0.05 beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | -$0.33 / -$0.02Alpha Vantage | -$0.31 miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.04 / -$0.04Alpha Vantage | +$0.08 beat | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 3, 2025 | -$0.02 / -$0.06Alpha Vantage | +$0.04 beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 12, 2024 | -$0.02 / -$0.05Alpha Vantage | +$0.03 beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 31 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $28.1M | $18.8M | $27.5M | $28.5M |
| Cost of what it sold | $10.1M | $6.1M | $10.1M | $10.2M |
| Gross profit | $17.9M | $12.7M | $17.4M | $18.3M |
| What it spent | ||||
| Research and development | $2.7M | $66.0K | $2.6M | $3.0M |
| Sales and admin | $12.1M | $10.5M | $12.2M | $10.7M |
| Other operating costs | $3.2M | -$3.8M | $2.5M | $2.9M |
| Total operating expenses | $18.0M | $6.9M | $17.4M | $16.6M |
| What was left | ||||
| Operating profit | -$89.0K | $5.8M | $27.0K | $1.7M |
| Interest on debt | $508.0K | $152.0K | — | — |
| Profit before tax | $703.0K | $3.4M | $1.2M | $2.8M |
| Tax | $82.0K | -$173.0K | $62.0K | -$42.4M |
| Net profit | $621.0K | $3.5M | $1.2M | $45.1M |
| EBITDA | $1.2M | $4.9M | $726.0K | $2.9M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
11 macro signals shaping BLFS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results